427 related articles for article (PubMed ID: 27247233)
1. Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines.
Olsen A; Chen Y; Ji Q; Zhu G; De Silva AD; Vilchèze C; Weisbrod T; Li W; Xu J; Larsen M; Zhang J; Porcelli SA; Jacobs WR; Chan J
mBio; 2016 May; 7(3):. PubMed ID: 27247233
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. Engineering Mycobacteria for the Production of Self-Assembling Biopolyesters Displaying Mycobacterial Antigens for Use as a Tuberculosis Vaccine.
Lee JW; Parlane NA; Rehm BHA; Buddle BM; Heiser A
Appl Environ Microbiol; 2017 Mar; 83(5):. PubMed ID: 28087528
[TBL] [Abstract][Full Text] [Related]
4. Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis.
Junqueira-Kipnis AP; de Oliveira FM; Trentini MM; Tiwari S; Chen B; Resende DP; Silva BD; Chen M; Tesfa L; Jacobs WR; Kipnis A
PLoS One; 2013; 8(11):e78639. PubMed ID: 24250805
[TBL] [Abstract][Full Text] [Related]
5. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
[TBL] [Abstract][Full Text] [Related]
6. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
Wu M; Li M; Yue Y; Xu W
Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
9. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
[TBL] [Abstract][Full Text] [Related]
11.
Jia Q; Masleša-Galić S; Nava S; Horwitz MA
mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
[TBL] [Abstract][Full Text] [Related]
12. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
Shen H; Wang C; Yang E; Xu Y; Liu W; Yan J; Wang F; Wang H
Microbiol Immunol; 2010 Aug; 54(8):435-41. PubMed ID: 20646207
[TBL] [Abstract][Full Text] [Related]
13. Influence of phthiocerol dimycocerosate on CD4(+) T cell priming and persistence during Mycobacterium tuberculosis infection.
Pinto R; Nambiar JK; Leotta L; Counoupas C; Britton WJ; Triccas JA
Tuberculosis (Edinb); 2016 Jul; 99():25-30. PubMed ID: 27450001
[TBL] [Abstract][Full Text] [Related]
14. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
[TBL] [Abstract][Full Text] [Related]
15. New TB vaccines: is there a requirement for CD8 T cells?
Boom WH
J Clin Invest; 2007 Aug; 117(8):2092-4. PubMed ID: 17671648
[TBL] [Abstract][Full Text] [Related]
16. Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha.
Basu S; Pathak SK; Banerjee A; Pathak S; Bhattacharyya A; Yang Z; Talarico S; Kundu M; Basu J
J Biol Chem; 2007 Jan; 282(2):1039-50. PubMed ID: 17095513
[TBL] [Abstract][Full Text] [Related]
17. Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection.
Cheng Y; Schorey JS
Eur J Immunol; 2013 Dec; 43(12):3279-90. PubMed ID: 23943377
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of IL-1+IL-6+TNF-α with Mycobacterium tuberculosis infected macrophages vaccine induces better protective T cell memory than BCG.
Singh V; Jain S; Gowthaman U; Parihar P; Gupta P; Gupta UD; Agrewala JN
PLoS One; 2011 Jan; 6(1):e16097. PubMed ID: 21283805
[TBL] [Abstract][Full Text] [Related]
19. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
Singh S; Saraav I; Sharma S
Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
